Peripheral arterial disease

Process (a) Proportion of people who have symptoms of PAD who receive a clinical assessment and ABPI measurement. Numerator: the number of people in the denominator receiving a clinical assessment and ABPI measurement. Denominator: the number of people who have symptoms of PAD. Data source: Local data collection. (b) Proportion of people who are at risk of developing PAD who receive a clinical assessment and ABPI measurement. Numerator: the number of people in the denominator receiving a clinical assessment and ABPI measurement. Denominator: the number of people at risk of developing PAD. Data source: Local data collection. Outcome Disease severity at diagnosis. Data source: Local data collection. What the quality statement means for different audiences Service providers ensure that hand-held doppler ultrasounds are adequately available; that staff are trained to recognise the symptoms of PAD; and that people who have symptoms of PAD or who are at risk of developing it are offered a clinical assessment and ABPI measurement. Health and social care practitioners ensure that they are aware of the symptoms of PAD and the need to have these symptoms assessed; that they are aware of the risk factors for PAD; and that healthcare practitioners ensure that they offer
